Innovative Technology Combined Therapeutics has developed a proprietary modified mRNA platform that enables targeted protein expression with minimized off-target effects, highlighting their potential for partnerships in advanced therapeutics and personalized medicine.
Niche Market Focus The company's emphasis on protecting vulnerable populations from infectious diseases and curing cancer presents opportunities to collaborate with healthcare providers and governmental health agencies seeking innovative treatments.
Growth Potential With a modest revenue range of up to $10 million and recent funding of $250K, there is significant scope for expansion through strategic partnerships with larger biotech firms looking for breakthrough RNA technologies.
Strategic Positioning Operating in the competitive biotech landscape alongside giants like Roche, Johnson & Johnson, and Pfizer, Combined Therapeutics can leverage their unique platform to differentiate and establish a niche in targeted gene therapy markets.
Digital Presence An active online presence via WordPress and SEO tools indicates an openness to outreach and partnership opportunities, making them accessible for business development initiatives and potential collaborations.
$10B
$1B$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10BCombined Therapeutics uses 8 technology products and services including Cloudflare, oEmbed, Font Awesome, and more. Explore Combined Therapeutics's tech stack below.
| Combined Therapeutics Email Formats | Percentage |
| First.Last@combinedtx.com | 50% |
| First.Last@combinedtx.com | 50% |
Biotechnology ResearchUnited States11-50 Employees
Combined Therapeutics has developed a unique modified mRNA platform which targets protein expression to specific tissues while reducing off target effects. Together with our partners, we are committed to using our platform to protect vulnerable populations from global infectious disease threats as well as to cure cancer.
Company Overview
Funding & FinancialsCombined Therapeutics has raised a total of $250K of funding over 1 rounds. Their latest funding round was raised on Dec 12, 2017 in the amount of $250K.
Combined Therapeutics's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsCombined Therapeutics has raised a total of $250K of funding over 1 rounds. Their latest funding round was raised on Dec 12, 2017 in the amount of $250K.
Combined Therapeutics's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com